Investor Relations

Gene Bio Medical is a Canadian biotechnology company focused on developing, manufacturing, and commercializing innovative diagnostic technologies that improve healthcare outcomes worldwide. By combining molecular diagnostics, artificial intelligence, advanced biomanufacturing, and precision health technologies, we are building a scalable platform positioned to address some of healthcare’s most pressing challenges.

Our core capabilities span molecular diagnostics, rapid point-of-care testing, microfluidics, bioinformatics, AI-enabled healthcare solutions, and advanced biomanufacturing. Through strategic collaborations with universities, healthcare organizations, industry partners, and government agencies, we accelerate the translation of scientific innovation into commercially successful healthcare products.

Innovation-Driven Growth

Gene Bio Medical has established a strong foundation through:

• Proprietary and emerging diagnostic technologies
• Advanced biomanufacturing capabilities
• Strategic academic and industry partnerships
• Regulatory expertise across global markets
• Commercialization and market access experience
• Scalable business models supporting international expansion

Our innovation pipeline includes molecular diagnostics, AI-assisted diagnostic platforms, microfluidic technologies, precision health solutions, and next-generation healthcare applications designed to improve disease detection, monitoring, and prevention.

Global Market Opportunity

The global demand for rapid diagnostics, precision medicine, digital health, and AI-enabled healthcare continues to accelerate. Gene Bio Medical is strategically positioned to capitalize on these opportunities through its integrated approach to innovation, manufacturing, regulatory execution, and commercialization.

As healthcare systems increasingly prioritize accessibility, affordability, and early disease detection, our technologies are designed to support healthcare providers, public health organizations, and patients across diverse markets worldwide.

Building Long-Term Value

Our vision is to become a global leader in AI-enabled diagnostics, precision health, and advanced biomanufacturing. By leveraging scientific excellence, strategic partnerships, and scalable commercialization capabilities, we are creating sustainable long-term value for customers, partners, communities, and future investors.

Through continuous innovation and disciplined execution, Gene Bio Medical is helping shape the future of healthcare while strengthening Canada’s position as a global biotechnology and life sciences leader.